{"DataElement":{"publicId":"2860486","version":"1","preferredName":"Person Metastatic Melanoma Histology Clinical Trial Eligibility Criteria Type","preferredDefinition":"the type of histology, microscopic identification of abnormal morphologic characteristics, associated with melanoma, a malignant and usually aggressive tumor composed of atypical neoplastic melanocytes that contain melanin, in tissues or sites distant from the original cancer as characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol.","longName":"2860480v1.0:2860481v1.0","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2860480","version":"1","preferredName":"Person Metastatic Melanoma Histology Clinical Trial Eligibility Criteria","preferredDefinition":"information related to microscopic identification of abnormal morphologic characteristics associated with melanoma, a malignant and usually aggressive tumor composed of atypical neoplastic melanocytes that contain melanin, in tissues or sites distant from the original cancer as characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol.","longName":"2236731v1.0:2860478v1.0","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2236731","version":"1","preferredName":"Person","preferredDefinition":"A human being.","longName":"C25190","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Person","conceptCode":"C25190","definition":"A human being.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9FC6DF7-66EB-4CAB-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-20","endDate":null,"createdBy":"UMLLOADER_MAGE","dateCreated":"2005-06-20","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2860478","version":"1","preferredName":"Metastatic Melanoma Histology Clinical Trial Eligibility Criteria","preferredDefinition":"(MET-uh-STAT-ik) Having to do with metastasis, which is the spread of cancer from one part of the body to another.:A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes that contain melanin.  Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma.  Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi.  Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system.  Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain. -- 2004:The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.:Elements of a personal medical history which are necessary to allow an individual to participate in a specific clinical trial.","longName":"C14174:C3224:C16681:C16112","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Metastatic","conceptCode":"C14174","definition":"A term referring to the clinical or pathologic observation of a tumor extension from its original site of growth to another anatomic site.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Melanoma","conceptCode":"C3224","definition":"A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes. Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma. Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi. Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Histology","conceptCode":"C16681","definition":"The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Clinical Trial Eligibility Criteria","conceptCode":"C16112","definition":"Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6771EEBB-BF95-AB2C-E040-BB89AD437865","latestVersionIndicator":"Yes","beginDate":"2009-04-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-04-13","modifiedBy":"ONEDATA","dateModified":"2009-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6771EEBB-BFA6-AB2C-E040-BB89AD437865","latestVersionIndicator":"Yes","beginDate":"2009-04-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-04-13","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2860481","version":"1","preferredName":"Melanoma Histology Clinical Trial Eligibility Criteria Type","preferredDefinition":"the histologic subdivision of a melanoma to determine clinical trial eligibility.","longName":"2860481v1.0","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"75","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Cutaneous melanoma with evidence of chronic sun damage","valueDescription":"Cutaneous Melanoma","ValueMeaning":{"publicId":"2860482","version":"1","preferredName":"Cutaneous Melanoma","longName":"2860482","preferredDefinition":"A malignant neoplasm derived from cells that are capable of forming melanin.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cutaneous Melanoma","conceptCode":"C3510","definition":"A primary melanoma arising from atypical melanocytes in the skin.  Precursor lesions include acquired and congenital melanocytic nevi, and dysplastic nevi.  Several histologic variants have been recognized, including superficial spreading melanoma, acral lentiginous melanoma, nodular melanoma, and lentigo maligna melanoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"67719CEB-4934-A191-E040-BB89AD430A4C","latestVersionIndicator":"Yes","beginDate":"2009-04-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-04-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"67719CEB-494D-A191-E040-BB89AD430A4C","beginDate":"2009-04-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-04-13","modifiedBy":"ONEDATA","dateModified":"2009-04-13","deletedIndicator":"No"},{"value":"Acral melanoma","valueDescription":"Acral Lentiginous Malignant Melanoma","ValueMeaning":{"publicId":"2860483","version":"1","preferredName":"Acral Lentiginous Malignant Melanoma","longName":"2860483","preferredDefinition":"A form of melanoma occurring most often on the plantar, palmar, subungual, and periungual skin. It presents as a pigmented macular lesion with irregular borders. Morphologically, it consists of atypical spindled and dendritic melanocytes. The epidermis is often hyperplastic and there is pagetoid infiltration of the epidermis by anaplastic cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acral Lentiginous Melanoma","conceptCode":"C4022","definition":"A form of melanoma occurring most often on the plantar, palmar, subungual, and periungual skin.  It presents as a pigmented macular lesion with irregular borders.  Morphologically, it consists of atypical spindled and dendritic melanocytes.  The epidermis is often hyperplastic and there is pagetoid infiltration of the epidermis by anaplastic cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"67719CEB-4957-A191-E040-BB89AD430A4C","latestVersionIndicator":"Yes","beginDate":"2009-04-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-04-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"67719CEB-4970-A191-E040-BB89AD430A4C","beginDate":"2009-04-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-04-13","modifiedBy":"ONEDATA","dateModified":"2009-04-13","deletedIndicator":"No"},{"value":"Mucosal melanoma","valueDescription":"Mucosal Lentiginous Melanoma","ValueMeaning":{"publicId":"2860484","version":"1","preferredName":"Mucosal Lentiginous Melanoma","longName":"2860484v1.00","preferredDefinition":"An acral lentiginous melanoma affecting mucosal surfaces.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mucosal Lentiginous Melanoma","conceptCode":"C48622","definition":"An acral lentiginous melanoma affecting mucosal surfaces.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"67719CEB-497A-A191-E040-BB89AD430A4C","latestVersionIndicator":"Yes","beginDate":"2009-04-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-04-13","modifiedBy":"KUMMEROA","dateModified":"2023-08-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"67719CEB-4993-A191-E040-BB89AD430A4C","beginDate":"2009-04-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-04-13","modifiedBy":"ONEDATA","dateModified":"2009-04-13","deletedIndicator":"No"},{"value":"Mucosal melanoma - Vulvovaginal Melanoma","valueDescription":"Mucosal melanoma - Vulvovaginal Melanoma","ValueMeaning":{"publicId":"3271049","version":"1","preferredName":"Mucosal melanoma - Vulvovaginal Melanoma","longName":"3271049","preferredDefinition":"Mucosal melanoma - Vulvovaginal Melanoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACD5F366-5EF3-CB83-E040-BB89AD431025","latestVersionIndicator":"Yes","beginDate":"2011-09-13","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-09-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"ACD5F366-5F0C-CB83-E040-BB89AD431025","beginDate":"2011-09-13","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-09-13","modifiedBy":"ONEDATA","dateModified":"2011-09-13","deletedIndicator":"No"},{"value":"Mucosal melanoma - Other","valueDescription":"Mucosal melanoma - Other","ValueMeaning":{"publicId":"3271048","version":"1","preferredName":"Mucosal melanoma - Other","longName":"3271048","preferredDefinition":"Mucosal melanoma - Other","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACD5F366-5ED0-CB83-E040-BB89AD431025","latestVersionIndicator":"Yes","beginDate":"2011-09-13","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-09-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"ACD5F366-5EE9-CB83-E040-BB89AD431025","beginDate":"2011-09-13","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-09-13","modifiedBy":"ONEDATA","dateModified":"2011-09-13","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"67719CEB-491F-A191-E040-BB89AD430A4C","latestVersionIndicator":"Yes","beginDate":"2009-04-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-04-13","modifiedBy":"ALAIS","dateModified":"2011-09-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811835","version":"1","longName":"Melanoma","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811954","version":"1","longName":"Eligibility Criteria","context":"CTEP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Metastatic melanoma subtype","type":"Preferred Question Text","description":"Metastatic melanoma subtype","url":null,"context":"CTEP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"67719CEB-499D-A191-E040-BB89AD430A4C","latestVersionIndicator":"Yes","beginDate":"2009-04-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-04-13","modifiedBy":"CAMPBELB","dateModified":"2009-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}